We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

612 hedge funds and large institutions have $10.7B invested in Charles River Laboratories in 2023 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 252 increasing their positions, 203 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 252 | Existing positions reduced: 203

5% more capital invested

Capital invested by funds: $10.3B → $10.7B (+$474M)

0.21% less ownership

Funds ownership: 100.16% → 99.94% (-0.21%)

8% less first-time investments, than exits

New positions opened: 67 | Existing positions closed: 73

1% less funds holding

Funds holding: 620 → 612 (-8)

16% less call options, than puts

Call options by funds: $29.3M | Put options by funds: $34.8M

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
612
Holders Change
-8
Holders Change %
-1.29%
% of All Funds
9.61%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
67
Increased
252
Reduced
203
Closed
73
Calls
$29.3M
Puts
$34.8M
Net Calls
-$5.51M
Net Calls Change
-$16.3M

Top Buyers

1
BlackRock
BlackRock
New York
+$81.8M
2
AI
Ariel Investments
Illinois
+$72.6M
3
ClearBridge Investments
ClearBridge Investments
New York
+$68.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$50.8M
5
MBI
Montrusco Bolton Investments
Quebec, Canada
+$43.7M

Top Sellers

1
Marshall Wace
Marshall Wace
United Kingdom
-$105M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$79.5M
3
JSP
Jackson Square Partners
California
-$62.2M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$60M
5
FAM
Fred Alger Management
New York
-$44.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
176
EagleClaw Capital Management
Massachusetts
$4.29M +$383K +1,925 +10%
Ensign Peak Advisors
177
Ensign Peak Advisors
Utah
$4.27M +$99.5K +500 +3%
GF
178
Gabelli Funds
New York
$4.25M – – –
IECM
179
Intrinsic Edge Capital Management
Illinois
$4.21M +$3.98M +20,000 New
PAMS
180
Pictet Asset Management (Switzerland)
Switzerland
$4.15M -$50.9K -256 -1%
MS
181
Madden Securities
Texas
$4.12M -$227K -1,141 -5%
Asset Management One
182
Asset Management One
Japan
$4.02M -$335K -1,683 -8%
Mirae Asset Global Investments
183
Mirae Asset Global Investments
South Korea
$4M +$95.3K +479 +3%
GCM
184
Geneva Capital Management
Wisconsin
$3.87M -$208K -1,044 -5%
Korea Investment Corp
185
Korea Investment Corp
South Korea
$3.83M +$249K +1,249 +7%
Lazard Asset Management
186
Lazard Asset Management
New York
$3.81M +$568K +2,855 +19%
UF
187
Univest Financial
Pennsylvania
$3.67M +$3.47M +17,441 New
BCM
188
Buckhead Capital Management
Georgia
$3.66M -$531K -2,667 -13%
Mawer Investment Management
189
Mawer Investment Management
Alberta, Canada
$3.63M +$285K +1,434 +9%
JIC
190
Johnson Investment Counsel
Ohio
$3.6M -$52.7K -265 -2%
SOADOR
191
State of Alaska Department of Revenue
Alaska
$3.42M -$133K -666 -4%
Royal London Asset Management
192
Royal London Asset Management
United Kingdom
$3.41M – – –
Squarepoint
193
Squarepoint
New York
$3.36M +$3.18M +16,000 New
Macquarie Group
194
Macquarie Group
Australia
$3.34M -$1.11M -5,555 -26%
FAM
195
Fred Alger Management
New York
$3.34M -$44.1M -221,629 -93%
AMI
196
Amica Mutual Insurance
Rhode Island
$3.33M -$274K -1,378 -8%
PI
197
PFS Investments
Georgia
$3.31M -$42K -211 -1%
AB
198
Amalgamated Bank
New York
$3.29M -$566K -2,843 -15%
NW
199
NewEdge Wealth
Pennsylvania
$3.23M +$122K +615 +4%
MA
200
Mudita Advisors
United Kingdom
$3.15M +$2.98M +15,000 New
6 7
8
9 10

CRL Hedge Fund Activity: Q2 2023 in Review

612 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2023, worth a combined $10.7B — up 4.6% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of CRL and 67 opened new positions — a net loss of 6 holders — while 203 trimmed existing stakes and 252 added.

The largest buyer was BlackRock, adding an estimated $81.8M. The largest seller was Marshall Wace, cutting an estimated $105M.

  • 612 institutional investors held Charles River Laboratories (CRL) as of Q2 2023, down from 620 in Q1 2023.
  • Funds reported $10.7B of Charles River Laboratories stock for Q2 2023, up 4.6% quarter-over-quarter.
  • 67 funds opened new Charles River Laboratories positions in Q2 2023 and 73 closed out, a net change of -6 holders.
  • The largest Charles River Laboratories buyer in Q2 2023 was BlackRock, an estimated $81.8M added.
  • The largest Charles River Laboratories seller in Q2 2023 was Marshall Wace, an estimated $105M sold.

Based on aggregated 13F filings for Q2 2023.